QQ客服 官方微博 反馈留言

	Ginkgol C17:1 inhibits tumor growth by blunting the EGF- PI3K/Akt signaling pathway
	Li Yueying[1]; Liu Jun[2]; Yang Xiaoming[3]; Dong Yan[4]; Liu Yali[5]; Chen Min[6]
刊名	Journal of biomedical research
	2017
卷号	31期号:3页码:232-239
ISSN号	1674-8301
DOI	http://dx.doi.org/10.7555/JBR.31.20160039
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5351033
专题	江苏大学
作者单位	1.[1]School of Medicine and Institute of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, China. 2.[2]Institute of Life Sciences and Jiangsu University, Zhenjiang, Jiangsu 212013, China. 3.[3]School of Food and Biological Engineering, Jiangsu University, Zhenjiang, Jiangsu 212013, China. 4.[4]School of Medicine,Jiangsu University, Zhenjiang, Jiangsu 212013, China. 5.[5]School of Food and Biological Engineering, Jiangsu University, Zhenjiang, Jiangsu 212013, China. 6.[6]School of Medicine,Jiangsu University, Zhenjiang, Jiangsu 212013, China.
推荐引用方式 GB/T 7714	Li Yueying[1],Liu Jun[2],Yang Xiaoming[3],et al. Ginkgol C17:1 inhibits tumor growth by blunting the EGF- PI3K/Akt signaling pathway[J]. Journal of biomedical research,2017,31(3):232-239.
APA	Li Yueying[1],Liu Jun[2],Yang Xiaoming[3],Dong Yan[4],Liu Yali[5],&Chen Min[6].(2017).Ginkgol C17:1 inhibits tumor growth by blunting the EGF- PI3K/Akt signaling pathway.Journal of biomedical research,31(3),232-239.
MLA	Li Yueying[1],et al."Ginkgol C17:1 inhibits tumor growth by blunting the EGF- PI3K/Akt signaling pathway".Journal of biomedical research 31.3(2017):232-239.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。